世界のイマチニブ薬市場 2019年

【英語タイトル】Global Imatinib Drug Market Professional Survey Report 2019

QYResearchが出版した調査資料(QYR20FB00400)・商品コード:QYR20FB00400
・発行会社(調査会社):QYResearch
・発行日:2019年11月
・ページ数:101
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥371,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,250 ⇒換算¥556,500見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,000 ⇒換算¥742,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
※本調査レポートは、イマチニブ薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、タブレット、カプセルに、用途別には、慢性骨髄性白血病、消化管間質腫瘍、その他にセグメント区分し、イマチニブ薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・イマチニブ薬の世界市場概要
・イマチニブ薬の製造コスト構成分析
・イマチニブ薬の開発・製造工場分析
・主要メーカーの主な指標(生産能力、売上、価格分析)
・イマチニブ薬の地域別分析(生産、売上、主要メーカー、輸出・輸入)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・イマチニブ薬のセグメント分析(種類別)
(タブレット、カプセル)
・イマチニブ薬のセグメント分析(用途別)
(慢性骨髄性白血病、消化管間質腫瘍、その他)
・イマチニブ薬の主要メーカー別分析(生産拠点、製品概要、生産・売上実績)
(Novartis、Glenmark Pharmaceuticals Ltd.、Sun Pharmaceuticals、Actavis Generics、Dr. Reddy's Laboratories、Teva Pharmaceutical Industries Ltd.、Sanofi S.A.、Cipla Inc.、Apotex Inc.、Mylan Pharms Inc.)
・イマチニブ薬の市場規模予測(2019年~2025年)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス(市場動向、機会、成長要因、課題、影響因子)
...
【レポートの概要】

Imatinib is a chemotherapy drug that acts by reducing or preventing the progression of cancer cells. This drug is used for the treatment of certain cancers such as chronic myeloid leukemia, acute lymphoblastic leukemia, gastrointestinal tumors, certain skin tumors (dermatofibrosarcoma protuberans), and myelodysplastic/myeloproliferative diseases.
Growth in prevalence of cancer, increase in demand for target drug therapy, and patent expiry of imatinib drug are expected to drive the imatinib drug market. Furthermore, rise in healthcare expenditure and increase in awareness of cancer by government and private organizations are anticipated to boost the market growth.

The global Imatinib Drug market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Imatinib Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Imatinib Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Imatinib Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Imatinib Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Novartis
Glenmark Pharmaceuticals Ltd.
Sun Pharmaceuticals
Actavis Generics
Dr. Reddy’s Laboratories
Teva Pharmaceutical Industries Ltd.
Sanofi S.A.
Cipla Inc.
Apotex Inc.
Mylan Pharms Inc.

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Tablets
Capsules

Segment by Application
Chronic myelogenous leukemia
Gastrointestinal stromal tumors
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Imatinib Drug
1.1 Definition of Imatinib Drug
1.2 Imatinib Drug Segment by Type
1.2.1 Global Imatinib Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Tablets
1.2.3 Capsules
1.3 Imatinib Drug Segment by Applications
1.3.1 Global Imatinib Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Chronic myelogenous leukemia
1.3.3 Gastrointestinal stromal tumors
1.3.4 Others
1.4 Global Imatinib Drug Overall Market
1.4.1 Global Imatinib Drug Revenue (2014-2025)
1.4.2 Global Imatinib Drug Production (2014-2025)
1.4.3 North America Imatinib Drug Status and Prospect (2014-2025)
1.4.4 Europe Imatinib Drug Status and Prospect (2014-2025)
1.4.5 China Imatinib Drug Status and Prospect (2014-2025)
1.4.6 Japan Imatinib Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Imatinib Drug Status and Prospect (2014-2025)
1.4.8 India Imatinib Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Imatinib Drug
2.3 Manufacturing Process Analysis of Imatinib Drug
2.4 Industry Chain Structure of Imatinib Drug

3 Development and Manufacturing Plants Analysis of Imatinib Drug
3.1 Capacity and Commercial Production Date
3.2 Global Imatinib Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Imatinib Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Imatinib Drug Production and Capacity Analysis
4.2 Imatinib Drug Revenue Analysis
4.3 Imatinib Drug Price Analysis
4.4 Market Concentration Degree

5 Imatinib Drug Regional Market Analysis
5.1 Imatinib Drug Production by Regions
5.1.1 Global Imatinib Drug Production by Regions
5.1.2 Global Imatinib Drug Revenue by Regions
5.2 Imatinib Drug Consumption by Regions
5.3 North America Imatinib Drug Market Analysis
5.3.1 North America Imatinib Drug Production
5.3.2 North America Imatinib Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Imatinib Drug Import and Export
5.4 Europe Imatinib Drug Market Analysis
5.4.1 Europe Imatinib Drug Production
5.4.2 Europe Imatinib Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Imatinib Drug Import and Export
5.5 China Imatinib Drug Market Analysis
5.5.1 China Imatinib Drug Production
5.5.2 China Imatinib Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Imatinib Drug Import and Export
5.6 Japan Imatinib Drug Market Analysis
5.6.1 Japan Imatinib Drug Production
5.6.2 Japan Imatinib Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Imatinib Drug Import and Export
5.7 Southeast Asia Imatinib Drug Market Analysis
5.7.1 Southeast Asia Imatinib Drug Production
5.7.2 Southeast Asia Imatinib Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Imatinib Drug Import and Export
5.8 India Imatinib Drug Market Analysis
5.8.1 India Imatinib Drug Production
5.8.2 India Imatinib Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Imatinib Drug Import and Export

6 Imatinib Drug Segment Market Analysis (by Type)
6.1 Global Imatinib Drug Production by Type
6.2 Global Imatinib Drug Revenue by Type
6.3 Imatinib Drug Price by Type

7 Imatinib Drug Segment Market Analysis (by Application)
7.1 Global Imatinib Drug Consumption by Application
7.2 Global Imatinib Drug Consumption Market Share by Application (2014-2019)

8 Imatinib Drug Major Manufacturers Analysis
8.1 Novartis
8.1.1 Novartis Imatinib Drug Production Sites and Area Served
8.1.2 Novartis Product Introduction, Application and Specification
8.1.3 Novartis Imatinib Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Glenmark Pharmaceuticals Ltd.
8.2.1 Glenmark Pharmaceuticals Ltd. Imatinib Drug Production Sites and Area Served
8.2.2 Glenmark Pharmaceuticals Ltd. Product Introduction, Application and Specification
8.2.3 Glenmark Pharmaceuticals Ltd. Imatinib Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Sun Pharmaceuticals
8.3.1 Sun Pharmaceuticals Imatinib Drug Production Sites and Area Served
8.3.2 Sun Pharmaceuticals Product Introduction, Application and Specification
8.3.3 Sun Pharmaceuticals Imatinib Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Actavis Generics
8.4.1 Actavis Generics Imatinib Drug Production Sites and Area Served
8.4.2 Actavis Generics Product Introduction, Application and Specification
8.4.3 Actavis Generics Imatinib Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Dr. Reddy’s Laboratories
8.5.1 Dr. Reddy’s Laboratories Imatinib Drug Production Sites and Area Served
8.5.2 Dr. Reddy’s Laboratories Product Introduction, Application and Specification
8.5.3 Dr. Reddy’s Laboratories Imatinib Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Teva Pharmaceutical Industries Ltd.
8.6.1 Teva Pharmaceutical Industries Ltd. Imatinib Drug Production Sites and Area Served
8.6.2 Teva Pharmaceutical Industries Ltd. Product Introduction, Application and Specification
8.6.3 Teva Pharmaceutical Industries Ltd. Imatinib Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Sanofi S.A.
8.7.1 Sanofi S.A. Imatinib Drug Production Sites and Area Served
8.7.2 Sanofi S.A. Product Introduction, Application and Specification
8.7.3 Sanofi S.A. Imatinib Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Cipla Inc.
8.8.1 Cipla Inc. Imatinib Drug Production Sites and Area Served
8.8.2 Cipla Inc. Product Introduction, Application and Specification
8.8.3 Cipla Inc. Imatinib Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Apotex Inc.
8.9.1 Apotex Inc. Imatinib Drug Production Sites and Area Served
8.9.2 Apotex Inc. Product Introduction, Application and Specification
8.9.3 Apotex Inc. Imatinib Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Mylan Pharms Inc.
8.10.1 Mylan Pharms Inc. Imatinib Drug Production Sites and Area Served
8.10.2 Mylan Pharms Inc. Product Introduction, Application and Specification
8.10.3 Mylan Pharms Inc. Imatinib Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served

9 Development Trend of Analysis of Imatinib Drug Market
9.1 Global Imatinib Drug Market Trend Analysis
9.1.1 Global Imatinib Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Imatinib Drug Regional Market Trend
9.2.1 North America Imatinib Drug Forecast 2019-2025
9.2.2 Europe Imatinib Drug Forecast 2019-2025
9.2.3 China Imatinib Drug Forecast 2019-2025
9.2.4 Japan Imatinib Drug Forecast 2019-2025
9.2.5 Southeast Asia Imatinib Drug Forecast 2019-2025
9.2.6 India Imatinib Drug Forecast 2019-2025
9.3 Imatinib Drug Market Trend (Product Type)
9.4 Imatinib Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Imatinib Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer



【掲載企業】

Novartis、Glenmark Pharmaceuticals Ltd.、Sun Pharmaceuticals、Actavis Generics、Dr. Reddy's Laboratories、Teva Pharmaceutical Industries Ltd.、Sanofi S.A.、Cipla Inc.、Apotex Inc.、Mylan Pharms Inc.

★調査レポート[世界のイマチニブ薬市場 2019年] (コード:QYR20FB00400)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のイマチニブ薬市場 2019年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆